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Abstract 
Introduction: Laparoscopic adrenalectomy is the gold standard management of benign adrenal masses and isolated metastases to adrenal 
glands. Two techniques of endoscopic adrenalectomy: lateral transperitoneal approach (LTA) and posterior retroperitoneal approach (PRA) 
seem to be equally safe and effective. Recent studies suggest advantages of PRA over LTA in terms of lower intensity of postoperative 
pain, shorter hospital stay, faster recovery, and lower early morbidity. However, PRA involves high insufflation pressure of CO2 within 
a limited retroperitoneal space. 
The aim of our study was to prospectively assess the effect of LTA versus PRA laparoscopic adrenalectomies on renal function.
Material and methods: We randomly assigned patients referred for unilateral adrenalectomy to either LTA (n = 33) or PRA (n = 44). The 
inclusion criteria were: hormonal activity and/or tumour diameter > 4 cm and/or suspicion of metastasis to adrenal gland. The exclusion 
criteria comprised: tumours > 8 cm, results of imaging studies suggesting primary invasive malignancy, and refusal to undergo ran-
domisation. The patients were prospectively followed for a minimum of six months. Serum creatinine, cystatin C, and urinary neutrophil 
gelatinase-associated lipocalin (NGAL) were measured preoperatively and at postoperative days: 1, 7, and 30. 
Results: We found increased concentrations of urinary NGAL at day 1 following laparoscopic adrenalectomy using PRA, as compared 
to LTA. Patients undergoing right-sided PRA had increased creatinine concentrations, as compared to left-sided PRA. Patients with 
aldosterone-producing adenoma had decreased preoperative eGFR as compared to subjects with non-functioning incidentaloma. NGAL 
increased significantly in this group postoperatively. All the disturbances normalised within one month postoperatively. 
Conclusions: Renal function impairment after PRA may result from compression of inferior vena cava by high retroperitoneal pressure 
during right-sided adrenalectomy. Despite the transient character of the observed abnormalities, we suggest that patients with high risk 
of acute kidney injury may benefit from an alternative technique of adrenalectomy using LTA. (Endokrynol Pol 2019; 70 (5): 409–416)
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Introduction
Adrenal masses belong to the most prevalent of all 
tumours found in humans. Reported in approximately 
3% of middle-aged adults, their prevalence increases to 
10% in the elderly [1–3]. Only tumours with hormonal 
activity or risk of malignancy require surgical treatment 
[4–7]. Minimally invasive techniques are gaining accep-
tance in the management of many diseases, including 
adrenal pathologies [8–10]. Laparoscopic adrenalec-
tomy is now the gold standard of surgical treatment for 
benign adrenal masses [11]. Currently, two approaches 
are recommended for laparoscopic adrenalectomy: 
lateral transperitoneal approach (LTA) and posterior 
retroperitoneal approach (PRA) [12]. Both LTA and 
PRA are associated with very low rates of perioperative 
complications. For most adrenal lesions requiring surgi-
cal treatment, adrenalectomy can be performed safely 
and effectively with either LTA or PRA approach. The 
choice usually depends on the surgeon’s preference; 
however, an increasing volume  of data suggest that 
PRA is superior to LTA due to shorter operative time, 
lower blood loss, lower postoperative pain, faster re-
covery, improved cost-effectiveness, lower morbidity, 
abolished risk of surgical site herniation, and shorter 
hospital stay [11–13]. Nevertheless, PRA requires much 
higher pressure of CO2 insufflation as compared to 
LTA (25 vs. 12 mm Hg). As a consequence, renal veins 
and inferior vena cava during right-sided PRA are 
compressed for as long as 30–150 minutes, depending 
on the difficulty of the operation and the surgeon’s ex-
perience [13–15]. In some patients after adrenalectomy 
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ity, and ionogram. In patients with suspicion of metastatic adrenal 
masses, positron emission tomography with 18-fluorodeoxyglucose 
was used to rule out disseminated disease. 
All patients with suspected pheochromocytoma were prepared for 
the operation for 10–14 days with alpha-adrenergic antagonists, 
and for at least two days before surgery beta-adrenergic block-
ade was added. Primary hyperaldosteronism patients obtained 
potassium-sparing diuretics and electrolyte supplementation pre-
operatively. All patients were admitted to hospital one day before 
surgery. Low-molecular-weight heparin (Enoxaparin 40 mg) was 
administered subcutaneously 12 hours preoperatively. Prophylactic 
antibiotic (1000 mg cephazolin) was infused intravenously within 
half an hour before the operation. All patients gave informed 
consent for participation in the study. The study was approved 
by the University Ethics Committee and obtained Study Registry 
Number R-I-002/66/2015.
Interventions
All patients underwent unilateral total adrenalectomy under gen-
eral anaesthesia. All the operations were performed by a single sur-
geon with experience in performing laparoscopic adrenalectomies 
by both approaches: LTA and PRA. For LTA the lateral decubitus 
position was used. Pneumoperitoneum was created using a Veres 
needle for left LTA adrenalectomy and Hasson technique for right 
LTA adrenalectomy, and the pressure of CO2 was set at 12 mm Hg 
for both. For left LTA three trocars (two 10 mm trocars and a 5 mm 
trocar) were inserted below the costal arch. For all right LTA and 
selected left LTA adrenalectomies an additional 5 mm trocar was 
placed in the mid-axillary line for liver retraction. A 30° laparoscope 
was used in all patients. After inspection and freeing of adhesions, 
for left LTA we mobilised the splenic flexure of the colon and the 
spleen and for right LTA — the right lobe of the liver. Left renal vein 
or inferior vena cava were identified, respectively. The main adrenal 
vein was ligated using a bipolar advanced haemostatic instrument, 
a deterioration of renal function has been reported 
(when an aldosterone-producing adenoma was identi-
fied) [16–18]. According to our knowledge, the impact 
of laparoscopic adrenalectomy on renal function has 
not yet been studied in a prospective randomised trial.
The aim of this study was to compare prospectively 
the impact of different techniques of laparoscopic adre-
nalectomy (either LTA or PRA) on renal function. 
Material and methods
Study design
We assessed prospectively all patients referred for elective unilateral 
adrenalectomy between February 2015 and June 2018 for eligibil-
ity in this trial (Fig. 1). Inclusion criteria were: hormonal, tumour 
diameter > 4 cm, and/or suspicion of metastasis. Exclusion criteria 
were: tumours > 8 cm (larger tumours cannot be operated by 
PRA due to limited space), primary invasive malignancy suspicion 
based on imaging studies, and refusal to undergo randomisation. 
We randomly assigned eligible patients to either LTA or PRA. The 
sample size was calculated on the assumption that a 20% change in 
studied parameters should be clinically relevant. To ascertain that 
the study has 90% power, 24 patients would be required in each 
arm. Assuming possible losses to follow-up we decided to include 
at least 33 patients in each group.
Preoperative workup
Each patient had spiral computed tomography with contrast ac-
cording to adrenal protocol. Hormonal function was assessed with 
urinary metoxycatecholamines, ACTH, diurnal cortisol, dexametha-
sone suppression test, DHEAS, serum aldosterone and renin activ-




ź 
ź 

ź 











Figure 1. Flow diagram of the study (accepted for publication in Videosurgery and Other Minimally Invasive Techniques)
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and so were all remaining vessels. Polymer clips were used only 
for vessels 7 mm in diameter. After resection with surrounding fat, 
the adrenal gland was placed in an extraction bag and morcellated 
when the edges of the extraction bag were 2 cm outside. Control 
of the operative field and aspiration of any visible blood was 
performed. The bed of the adrenal gland was flushed with 0.9% 
saline and aspirated. All wounds 10 mm or larger were closed with 
a laparoscopic port site closure device. Interrupted sutures were 
used for wound closure, and sterile gauze dressing was applied.
For PRA a prone position was used with hip and knee joints flexed. 
The first incision was performed at the tip of the 12th rib. Blunt 
scissors were used to penetrate the retroperitoneal space. Under 
digital control three trocars (12, 10, and 5 mm) were introduced 
into the retroperitoneal space. CO2 was insufflated at a pressure of 
25 mm Hg. A 30° laparoscope was used. Gerota’s fascia was opened 
bluntly to identify the upper pole of the kidney. For right PRA the 
inferior vena cava was exposed to dissect the adrenal vein safely. 
For left PRA, due to the longer segment of adrenal vein, exposure 
of the left renal vein was not necessary. Further steps were similar 
to LTA. Skin and subfascial space were anaesthetised with 10 ml 
0.5% Bupivacain for postoperative analgesia. Drains were not used 
— this approach has previously been confirmed to be safe [19].
Postoperative management
All patients were offered standard postoperative analgesia and 
were encouraged to drink fluids and ambulate as early as two 
hours postoperatively. Starting from the next morning, a full diet 
was recommended. Routinely the patients were discharged home 
24 hours postoperatively. All patients with hypercortisolism ob-
tained postoperative hydrocortisone in gradually decreasing doses 
according to clinical assessment and serum cortisol concentrations. 
The patients were followed-up in the outpatient department.
Laboratory measurements 
Fasting venous blood and urine were taken preoperatively (Day 
0), in the morning of the first postoperative day (Day 1), and one 
week (Day 7) and one month (Day 30) after the procedure. After clot 
formation the blood was centrifuged for 10 minutes at 1000 g and 
stored at –80°C until final analyses. For the analysis of creatinine, the 
enzymatic method was used. Serum cystatin C was assayed by the 
immunoturbidimetric method. Neutrophil gelatinase-associated li-
pocalin (NGAL), also known as lipocalin-2, is an adipokine (adipose-
derived cytokine) transporting small lipophilic molecules, such as 
steroids and lipopolysaccharides. It has been reported to play roles 
in the induction of apoptosis in haematopoietic cells, transport of 
fatty acids and iron, modulation of inflammation, immunity, and 
metabolic homeostasis. Recently, NGAL has emerged as an early 
marker of renal impairment [20, 21]. NGAL was measured in urine 
by chemiluminescent microparticle immunoassay (CMIA). All 
parameters were determined using ARCHITECT 8200ci.
Statistical analysis
Statistica 13 for Windows (StatSoft, Krakow, Poland) software was 
used. Data distribution was verified using Shapiro-Wilk test. Assess-
ment with Kruskal-Wallis ANOVA test was performed for multiple 
independent groups and Mann-Whitney test for two independent 
samples. Dependent variables were compared using Wilcoxon test. 
For correlations we used Spearman test. We considered p < 0.05 
as significant.
Results
We assessed 95 patients for eligibility in the trial. 
Eighteen patients were excluded for reasons shown in 
Figure 1. Eligible patients were randomly assigned to 
undergo either LTA (33 patients) or PRA (44 patients), 
and all of them completed at least six months of fol-
low-up. Demographic data did not differ significantly 
between the groups (Tab. I). Sixty-two out of 77 patients 
were on hypotensive medication. The average number 
of drugs to treat hypertension was 1.94 ± 1.49, whereas 
at completion of follow-up it decreased to 1.38 ± 1.28. 
There were no patients fulfilling preoperative criteria of 
chronic kidney disease [22]. The clinical outcomes of op-
erations were accepted for publication in Videosurgery 
and Other Minimally Invasive Techniques. In short, 
both LTA and PRA proved safe and effective. Opera-
tive time tended to be longer for pheochromocytoma 
and malignant tumours, reflecting higher levels of dif-
ficulty in both clinical settings. Nevertheless, the safety 
Table I. Patients’ characteristics
LTA  
(n = 33)
PRA  
(n = 44)
p value
Age [years]
Mean ± SD 
(min–max)
61.2 ± 8.3
(44–84)
59.3 ± 10.2
(32–81)
NS
Gender 
Male
Female
13 (39%)
20 (61%)
21 (48%)
23 (52%)
NS
BMI [kg/m2]
mean ± SD 30.1 ± 6 29.1 ± 5.2 NS
Number of hypotensive 
drugs
ASA median (min–max)
2.0 ± 1.53 
3 (2-4)
1.89 ± 1.82 
3 (2-4)
NS 
NS
Tumour size: median 
(min–max)
4.1 (1.5–7.5) 4.0 (0.8–7.5) NS
Location
Right side
Left side
11 (33%)
22 (67%)
18 (40%)
26 (60%)
NS
Hormonal diagnosis
Pheochromocytoma
Cushing’s disease
Conn’s disease
Nonfunctioning tumour
4 (12%)
5 (15%)
2 (6%)
22 (67%)
9 (20%)
3 (7%)
4 (9%)
28 (64%)
NS
Pathological diagnosis
Pheochromocytoma 
Adenoma
Nodular hyperplasia
Myelolipoma
Ganglioneuroma
Cancer metastasis
Lymphangioma
2 (6%)
27 (82%)
1 (3%)
1 (3%)
1 (3%)
1 (3%)
0 (0%)
5 (11%)
31 (70%)
2 (5%)
1 (2.3%)
1 (2.3%)
3 (7%)
1 (2.3%)
NS
LTA — lateral transperitoneal approach; PRA — posterior retroperitoneal approach; 
SD — standard deviation; min-max — full range (minimum–maximum);  
NS — not significant; BMI — body mass index; ASA — operative risk 
according to the American Society of Anaesthesiologists
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and efficacy of a minimally invasive approach to both 
pheochromocytoma and selected adrenal malignancies 
have previously been confirmed [23, 24]. In our mate-
rial there were no conversions, no blood transfusions, 
or major complications within 30 days postoperatively. 
The only complication observed was pain continuing 
beyond seven days in four patients from the LTA and 
PRA groups. No medications were added postop-
eratively, other than analgesics, low-molecular-weight 
heparins, or hydrocortisone in patients with preopera-
tive hypercortisolism. 
Initial and postoperative creatinine concentrations 
were similar in LTA and PRA groups (Tab. II). However, 
the subgroup analysis showed that patients submitted 
to right adrenalectomy by PRA had increased serum 
concentrations of creatinine at postoperative day 1 (on 
average by 20%) as compared to left adrenalectomy by 
the same approach (p < 0.05) (Tab. II, Fig. 2). At the same 
time, at day 1 patients who underwent right adrenal-
ectomy by PRA had higher creatinine concentrations 
than those assessed at day 0 (p < 0.05) (Tab. II, Fig. 2). 
At further time points, this difference was no longer 
significant as compared to the preoperative values and 
the patients with left adrenalectomy by PRA (Tab. II, 
Fig. 2). Finally, at day 30 the mean values returned to 
preoperative values.
The serum concentrations of cystatin C tended to 
follow creatinine levels; however, the differences did 
not reach statistical significance (Tab. II, Fig. 3). Never-
theless, we found a high positive correlation between 
cystatin C and creatinine serum concentrations assessed 
at postoperative day 1 (R = 0.7).
Urinary NGAL concentrations increased signifi-
cantly after adrenalectomies performed using PRA as 
compared to LTA at postoperative day 1 (Tab. II, Fig. 4). 
The difference between preoperative measurements 
and those taken 24 hours later reached on average 
58% (p < 0.001) and were greater after right than left 
adrenalectomies by PRA (+97% — p< 0.001 vs. +33% 
— p > 0.05) (Tab. II, Fig. 4). A week after the operation, 
urinary NGAL concentrations decreased significantly 
as compared to the measurements at day 1 in the 
whole PRA group (p < 0.001), left PRA (p < 0.05), and 
right PRA (p < 0.01) (Tab. II, Fig. 4). Thirty days post-
operatively the differences of preoperative levels and 
differences between groups were no longer significant.
Discussion
Ours is a pioneering study to compare the two most 
common techniques of laparoscopic adrenalectomy: 
LTA versus PRA, with regard to renal function. In this 
trial we demonstrated for the first time that PRA may 
cause transient impairment of renal function, as op- Ta
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posed to LTA. This has been witnessed by increased 
urinary NGAL concentrations at the first postoperative 
day (Tab. II, Fig. 4). 
Urinary NGAL has been reported to be the most 
sensitive maker of acute kidney injury when assessed 
24 hours postoperatively, superior to both creatinine 
and cystatin C [19]. Indeed, in our study urinary NGAL 
concentrations showed the highest increases at day 1 
postoperatively as compared to preoperative values in 
patients after PRA adrenalectomy (Tab. II). Even though 
PRA patients had significantly greater NGAL levels 
than LTA, subgroup analysis showed that only subjects 
after right PRA had significant postoperative increase in 
urinary NGAL (Tab. II, Fig. 4). Interestingly, preopera-
tive urinary NGAL concentrations tended to be greater 
than at one month postoperatively. This phenomenon 
might be associated with relative dehydration [25] of 
patients at admission to hospital due to fasting and 
administrative delays.
We found in a subgroup analysis that right-sided 
adrenalectomies by PRA resulted in a greater extent 
of renal function impairment than left-sided opera-
Figure 3. Serum concentrations of cystatin C in patients operated using posterior retroperitoneal approach: PRA-L — left adrenalectomy 
by posterior retroperitoneal approach; PRA-R — right adrenalectomy by posterior retroperitoneal approach. The mean concentration 
at day 0 was set at 100% separately for LTA and PRA groups to better visualise the differences between preoperative and postoperative 
measurements. Data shown as mean ± standard error of measurement
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Figure 2. Serum concentrations of creatinine in patients operated using posterior retroperitoneal approach: PRA-L — left adrenalectomy 
by posterior retroperitoneal approach; PRA-R — right adrenalectomy by posterior retroperitoneal approach. The mean concentration 
at day 0 was set at 100% separately for LTA and PRA groups to better visualise the differences between preoperative and postoperative 
measurements. Data shown as mean ± standard error of measurement; comparison to day 0: * — p < 0.05, comparison to PRA-L day 1: 
^ — p < 0.05
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tions. This was shown by both increased NGAL and 
creatinine concentrations (Tab. II, Fig. 2, 4). 
Creatinine is thought to be a universal index of 
kidney function. However, its serum concentration 
depends not only on glomerular filtration rate, but also 
on active secretion by the distal tubules [26]. A possible 
explanation of greater creatinine concentrations in 
serum after right compared to left adrenalectomy by 
PRA (Tab. II, Fig. 2) is compression of the inferior vena 
cava by the high pressure of retroperitoneal CO2 insuf-
flation during PRA (25 mm Hg), as opposed to pneu-
moperitoneum values during LTA (12 mm Hg). Taking 
into account the extensive exposition of inferior vena 
cava during right-sided PRA and the ratio of insuffla-
tion pressure to central venous pressure, we speculate 
that compression of the inferior vena cava may result 
in decreased glomerular filtration rate and possibly in 
decreased secretion by the distal tubules. 
In the present study cystatin C concentrations in 
serum tended to follow creatinine changes; however, 
they did not reach statistical significance (Tab. II, Fig. 
3). Nevertheless, cystatin C in our study showed a high 
positive correlation with creatinine levels, as assessed 
at day 1 postoperatively (R = 0.7). The fact might be 
partially explained by different effects of hypertensive 
drugs, especially those decreasing vascular resistance, 
which may cause factitious decrease in cystatin C [27, 
28].
Earlier studies on renal function concentrated exclu-
sively on patients with primary hyperaldosteronism, 
who underwent unilateral laparoscopic adrenalec-
tomy [16–18]. The main factors predicting impaired 
kidney function postoperatively were preoperative 
eGFR ≤ 102 ml/min/1.73 m2 and aldosterone to renin 
ratio ≥ 448 ng/dl:ng/ml/h [29]. Utsumi et al. [18] claimed 
that laparoscopic adrenalectomy itself did not impair 
renal function but elicited preoperative renal dam-
age masked by hyperfiltration. In our study only six 
patients (7.8%) were treated for primary hyperaldo-
steronism. Similarly to other publications, our patients 
with aldosterone-producing adenoma had lower initial 
eGFR when compared to subjects with non-functioning 
incidentaloma (72.3 ± 9.0 vs. 102.1 ± 8.9 ml/min/1.73m2; 
p < 0.05). Postoperatively their urinary NGAL concen-
trations increased significantly as assessed at day 1 in 
comparison to initial levels (p< 0.05) but returned to 
preoperative values within one month.
Interestingly, Kaga et al. [30] reported that hyper-
aldosteronism was also associated with new-onset 
dyslipidaemia postoperatively. Eighteen of 39 patients 
developed dyslipidaemia 12 months after laparoscopic 
adrenalectomy. The preoperative risk factors identi-
fied were: high body mass index (BMI) and decreased 
eGFR. Within our study group 37 out of 77 patients 
had BMI > 30 kg/m2 and three of them had BMI > 40 
kg/m2. This has not been the subject of this study; 
however, other publications demonstrate a close link 
between obesity, dyslipidaemia, metabolic syndrome, 
and other comorbidities [31-34]. The impact of hyper-
aldosteronism and high renin activity extends beyond 
cardiovascular system and renal function. The mecha-
nisms involved in aldosterone production have also 
been linked via interleukin-6 to mineral bone disorder 
[35–37]. 
Figure 4. Urinary concentrations of neutrophil gelatinase-associated lipocalin (NGAL) in patients operated using posterior retroperitoneal 
approach: PRA-L — left adrenalectomy by posterior retroperitoneal approach; PRA-R — right adrenalectomy by posterior retroperitoneal 
approach. The mean concentration at day 0 was set at 100% separately for LTA and PRA groups to better visualise the differences 
between preoperative and postoperative measurements. Data shown as mean ± standard error of measurement; comparison to day 0: 
*** — p < 0.001; comparison to day 1: # — p < 0.05, ### — p < 0.001
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Our study has several limitations. The patients 
included in the study are not homogenous in terms of 
clinical and pathological diagnoses; however, the differ-
ences between LTA and PRA groups are not significant. 
The groups are not of equal size – to avoid any selection 
bias, we decided to randomise all patients, without 
restraining the sizes of the groups. The study was not 
blinded, as it was not possible to keep the approach to 
adrenalectomy blind longer than for a few days. We did 
not measure the urine output of the patients. Finally, 
we could not eliminate the influence of medication on 
the obtained results (only 15 patients were free of any 
medication).
Conclusions
In this pioneering study we found increased concentra-
tions of urinary NGAL at day 1 following laparoscopic 
adrenalectomy using PRA, as compared to LTA. Patients 
undergoing right-sided PRA had increased creatinine 
concentrations, as compared to left-sided PRA. We 
speculate that this association may result from com-
pression of inferior vena cava by high retroperitoneal 
pressure during right-sided adrenalectomy by PRA. 
Even though the observed impairment of renal function 
has transient character, patients with high risk of acute 
kidney injury may benefit from adrenalectomy using 
LTA instead of PRA technique.
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